Compounding pharmacies that market microdosed GLP-1 medications for gradual weight loss, longevity, or other benefits typically provide their medications in a glass vial
In patients with pre-existing cardiovascular disease, optimization of cardiac medications may help mitigate heart rate increases
Staying on tirzepatide long-term is often achievable with simple lifestyle adjustments: eating smaller portions, staying hydrated, and increasing fiber intake gradually
Chinas weight-loss drug makers take on global giants as Novo Nordisk patent expires Patent expiry of blockbuster drug opens door for Chinese drug makers to challenge multinationals in booming weight-loss market Novo Nordisks blockbuster semaglutide, which generated about US$35 billion in global revenue last year, lost patent protection in China on March 20, clearing the way for rivals
Sterile water contains no preservatives, so once the vial is pierced, its susceptible to bacterial growth
Triple-action drugs can outperform traditional weight loss treatments